“Most respondents advocated for the wider use of telehealth and online platforms for post-treatment survivorship follow-up after the pandemic is resolved. Other suggestions to improve care after the pandemic included the routine use of virtual exams to observe images (e.g., mammography, CT scan), and the use of effective triaging of survivors’ needs over the phone, as well as strategies to improve the acceptability of telehealth among patients (such as the use of telehealth only after the first face-to-face appointment).”
This article, “Cancer survivorship care during COVID-19 – perspectives and recommendations from the MASCC survivorship study group,” was co-authored by our Chief Scientific Officer, Dr. Fred Ashbury. The VieCure platform includes remote patient monitoring and telehealth capabilities to provide practices with the tools to facilitate these new methods of engagement and as a tool to provide access to new revenue streams during these changing times.
Please read this article by clicking this link: Cancer survivorship care during COVID-19 - perspectives and recommendations from the MASCC survivorship study group
Cancer survivorship care
during COVID-19 - perspectives and recommendations from the MASCC survivorship study group
May 25, 2020
Alexandre Chen, Fred Ashbury, Margaret I Fitch, Bodga Koczwara, Raymond Javan Chan, MASCC Survivorship Study Group